Literature DB >> 9066091

Signal transduction in cavernous smooth muscle.

C G Stief1, T Noack, K E Andersson.   

Abstract

Knowledge of intracellular signal propagation in smooth-muscle tone regulation is of major importance to the understanding of both the physiology of erection and the pathophysiology of erectile dysfunction and the development of new and selective pharmacological agents in the treatment of erectile dysfunction. Cavernous smooth-muscle tone depends heavily on the amount of intracellular free Ca2+. In the resting state the sarcoplasmic free Ca2+ amounts to about 120-270 nM, whereas in the extracellular fluid the Ca2+ level is in the range of 1.5-2 mM. Electromechanical and pharmacomechanical coupling induces an increase in the levels of free sarcoplasmic Ca2+ by a factor of 2-3 to 550-700 nM that triggers myosin phosphorylation and subsequent smooth muscle contraction. In this case, modulation of membrane-bound ion channels and regulation of the intracellular second-messenger system are attractive and feasible targets for pharmacological intervention. Besides the amount of free sarcoplasmic Ca2+, smooth-muscle tone is also modulated by the regulation of Ca2+ sensitivity ("Ca-sensitization") and Ca(2+)-independent contraction processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066091     DOI: 10.1007/bf01275153

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

Review 1.  Pharmacology of calcium channels and smooth muscle.

Authors:  L Hurwitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

Review 2.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

3.  Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit.

Authors:  F Holmquist; C G Stief; U Jonas; K E Andersson
Journal:  Acta Physiol Scand       Date:  1991-11

4.  Physiology of erection and pharmacological management of impotence.

Authors:  T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

5.  Multiple cyclic nucleotide phosphodiesterases.

Authors:  J A Beavo; M Conti; R J Heaslip
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

Review 6.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

7.  Hemodynamics of erection in the monkey.

Authors:  T F Lue; T Takamura; R A Schmidt; A J Palubinskas; E A Tanagho
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

8.  Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle.

Authors:  B Himpens; T Kitazawa; A P Somlyo
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

Review 9.  Electrophysiological methods in smooth-muscle physiology. Corpus cavernosum in vitro.

Authors:  K Mandrek
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 10.  Regulation of actomyosin and contraction in smooth muscle.

Authors:  S Chacko; P A Longhurst
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

View more
  4 in total

1.  The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum.

Authors:  Ryosuke Takahashi; Junji Nishimura; Katsuya Hirano; Seiji Naito; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 2.  Causes of erectile dysfunction.

Authors:  Jeremy P W Heaton; Michael A Adams
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 3.  Vasoconstriction and vasodilation in erectile physiology.

Authors:  Thomas M Mills
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 2.862

Review 4.  Intracavernosal therapy: when oral agents fail.

Authors:  A Nehra
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.